{"gene":"RBP4","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2008,"finding":"STRA6 mediates bidirectional retinol transfer between RBP4 and cells; this transfer is enhanced by lecithin:retinol acyltransferase (LRAT) and is bidirectional, indicating STRA6 functions as a retinol channel/transporter. In zebrafish lacking Stra6, holo-Rbp4 causes nonspecific vitamin A excess in embryonic tissues, impairing retinoic acid receptor signaling; reducing Rbp4 levels alleviates these defects.","method":"Cell-based retinol transfer assay (NIH 3T3 fibroblasts expressing STRA6 ± LRAT); zebrafish loss-of-function (morpholino knockdown of stra6 and rbp4); pharmacological treatment","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstituted retinol transport in cultured cells with mechanistic follow-up, bidirectionality established, orthogonal in vivo zebrafish model with rescue experiment","pmids":["18316031"],"is_preprint":false},{"year":2012,"finding":"RBPR2 (RBP4 receptor-2) is a novel retinol transporter expressed primarily in liver and intestine that confers high-affinity RBP4 binding and retinol transport when expressed in cultured cells; RBPR2 knockdown reduces RBP4 binding and retinol transport. RBPR2 expression is suppressed by retinol and retinoic acid and correlates inversely with liver retinol stores in vivo, identifying it as a hepatic receptor for circulating RBP4.","method":"Heterologous expression in cultured cells (binding and transport assays); siRNA knockdown; in vivo correlation of RBPR2 expression with retinol stores","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional expression with binding/transport assay, knockdown confirmation, in vivo correlation; single lab but multiple orthogonal methods","pmids":["23105095"],"is_preprint":false},{"year":2014,"finding":"RBP4 directly activates adipose tissue antigen-presenting cells (APCs) through a JNK-dependent pathway, leading to CD4 T cell Th1 polarization and adipose tissue inflammation. Transfer of RBP4-activated APCs into normal mice is sufficient to induce adipose tissue inflammation, insulin resistance, and glucose intolerance.","method":"RBP4-overexpressing mouse model (RBP4-Ox); adoptive transfer of RBP4-activated APCs into normal mice; JNK pathway inhibition","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — adoptive transfer experiment establishes sufficiency, genetic model establishes necessity, pathway inhibition identifies JNK as mediator; replicated in follow-up study (PMID 26936962)","pmids":["24606904"],"is_preprint":false},{"year":2016,"finding":"RBP4-induced macrophage antigen presentation and T-cell activation requires MyD88 signaling and downstream MAPK (JNK, ERK, p38) and NF-κB pathways. In macrophages from MyD88−/− mice, RBP4 fails to stimulate TNF, IL-12, and IL-6 secretion or CD4 T-cell activation. In vivo blockade of antigen presentation with CTLA4-Ig reduces adipose tissue inflammation and improves insulin resistance in RBP4-Ox mice. RBP4−/− mice on high-fat diet show reduced adipose tissue inflammation and improved insulin sensitivity.","method":"MyD88−/− macrophages; pharmacological inhibition of JNK/ERK/p38/NF-κB; CTLA4-Ig treatment in vivo; RBP4−/− knockout mice on high-fat diet","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (MyD88 KO, RBP4 KO) and pharmacological loss-of-function, multiple orthogonal approaches, replication of mechanism from PMID 24606904","pmids":["26936962"],"is_preprint":false},{"year":2015,"finding":"Dominant-negative missense mutations in RBP4 greatly reduce retinol binding yet paradoxically increase RBP4 affinity for its cell-surface receptor STRA6. By occupying STRA6 nonproductively, these mutant proteins disrupt vitamin A delivery by wild-type RBP4 both within the fetus and, for maternally transmitted alleles, at the placenta, establishing a dominant-negative mechanism for ocular birth defects.","method":"Structural/biochemical analysis of mutant RBP4 retinol-binding and STRA6-binding affinities; genetic analysis of three human families with eye malformations; maternal transmission studies","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — biochemical characterization of mutant protein–receptor interaction combined with human genetic analysis demonstrating dominant-negative mechanism; multiple orthogonal approaches in single rigorous study","pmids":["25910211"],"is_preprint":false},{"year":2016,"finding":"Hepatocytes are the principal source of circulating RBP4. Liver-specific RBP4 knockout mice have undetectable circulating RBP4 despite intact and inducible adipose tissue RBP4 expression and secretion, demonstrating that adipocyte-derived RBP4 does not significantly contribute to circulating levels even in diet-induced insulin resistance.","method":"Hepatocyte-specific Cre-mediated RBP4 deletion (LRKO mice); measurement of serum RBP4 and adipose RBP4 expression/secretion in lean and obese states","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific genetic knockout with quantitative assessment of circulating and tissue RBP4; clear epistatic result","pmids":["27797907"],"is_preprint":false},{"year":2018,"finding":"Liver-specific overexpression of RBP4 via AAV to levels comparable to obesity-associated elevation does not impair glucose homeostasis in mice, even under high-fat diet challenge, indicating that modestly elevated liver-secreted circulating RBP4 is not itself causative for impaired glucose metabolism.","method":"Adeno-associated virus (AAV)-mediated liver-specific RBP4 overexpression; glucose tolerance tests; insulin clamp; high-fat diet challenge","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic gain-of-function model with multiple metabolic readouts; negative finding robustly established with rigorous controls","pmids":["30126844"],"is_preprint":false},{"year":2009,"finding":"HMGA1 transcription factor is required for basal and cAMP-induced RBP4 gene and protein expression. In Hmga1-knockout mice, basal and glucagon-induced RBP4 expression is severely attenuated. This identifies a cAMP–HMGA1–RBP4 pathway regulating glucose homeostasis, where RBP4 reduction correlates inversely with increased GLUT4 and activated Akt in skeletal muscle and fat.","method":"Hmga1 knockout mouse model; glucagon administration; cAMP treatment of cells; mRNA and protein quantification of RBP4 and GLUT4/Akt","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout and pharmacological stimulation, multiple readouts; single lab","pmids":["19460132"],"is_preprint":false},{"year":2015,"finding":"Hepatic RBP4 expression oscillates diurnally under circadian control. BMAL1 regulates hepatic RBP4 via its direct target DBP. Hepatic knockdown of RBP4 or DBP improves whole-body insulin sensitivity in a time-of-day-dependent manner; hepatic overexpression of RBP4 reverses insulin-sensitizing effects of liver-specific BMAL1 depletion, placing RBP4 as a hepatokine downstream of the circadian clock regulating glucose metabolism.","method":"Liver-specific Bmal1 knockout mice; recombinant adenovirus-mediated shRNA knockdown of Dbp or Rbp4 in liver; hepatic RBP4 overexpression; insulin sensitivity tests at different times of day","journal":"Diabetologia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic models (KO, KD, OE) with functional glucose metabolism readouts; single lab","pmids":["26564180"],"is_preprint":false},{"year":2014,"finding":"Circulating transthyretin (TTR) is a critical determinant of plasma RBP4 levels. Antisense oligonucleotide-mediated knockdown of TTR decreases circulating TTR and RBP4 by 80–95%, improving insulin sensitivity in obese mice (increased glucose infusion rate, greater suppression of hepatic glucose production, increased muscle glucose uptake), demonstrating that TTR-RBP4 complex formation is required for maintaining elevated circulating RBP4.","method":"TTR antisense oligonucleotide (ASO) treatment in ob/ob and high-fat diet mice; hyperinsulinemic-euglycemic clamp; hepatic glucose production measurement; insulin signaling in muscle","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological targeting of TTR-RBP4 interaction with quantitative metabolic phenotyping; multiple models and orthogonal readouts","pmids":["25524914"],"is_preprint":false},{"year":2018,"finding":"Human plasma RBP4, in addition to retinol, binds fatty acids (including palmitic and lauric acid) in its hydrophobic ligand-binding site. High-resolution crystal structures of human RBP4 from plasma, urine, and amniotic fluid all showed a fatty acid molecule bound in the retinol-binding pocket, confirmed by mass spectrometry.","method":"X-ray crystallography (high-resolution 3D structures of apo- and holo-RBP4 from plasma, urine, amniotic fluid); mass spectrometry confirmation of fatty acid binding","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures at high resolution with mass spectrometry confirmation; single lab but Tier 1 method","pmids":["29414511"],"is_preprint":false},{"year":2017,"finding":"STRA6, activated by RBP4, transduces a JAK2-STAT3 signaling cascade that promotes cancer stem cell maintenance in colon cancer. Downregulation of STRA6 or RBP4 decreases cancer stem cell fraction and sphere/tumor initiation frequency. High-fat diet increases STRA6 levels and promotes tumor growth in a xenograft model; STRA6 downregulation delays tumor initiation and impairs stemness marker expression.","method":"STRA6/RBP4 siRNA knockdown in colon cancer cells; sphere formation and tumor initiation assays; xenograft mouse model; high-fat diet mouse model","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in vitro and in vivo with defined stem cell phenotype; single lab, multiple approaches","pmids":["28689994"],"is_preprint":false},{"year":2017,"finding":"Retinol-free RBP4 (apo-RBP4), but not retinol-bound RBP4 (holo-RBP4), activates STRA6 signaling and induces insulin resistance. In vitro, apo-RBP4 prolongs RBP4–STRA6 interaction (shown by co-immunoprecipitation) and elevates JAK2/STAT5 cascade activation and SOCS3 expression, while decreasing IR/IRS1 phosphorylation and GLUT4 translocation. Exogenous apo-RBP4 injection into pregnant rats attenuates insulin sensitivity.","method":"Co-immunoprecipitation of RBP4 with STRA6 in human adipocytes treated with apo- vs. holo-RBP4; Western blotting of JAK2/STAT5/SOCS3/IR/IRS1; GLUT4 translocation by immunofluorescence; in vivo apo-RBP4 injection in pregnant rats","journal":"Archives of gynecology and obstetrics","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP distinguishing apo vs. holo forms, multiple signaling readouts, in vivo validation; single lab","pmids":["28528355"],"is_preprint":false},{"year":2020,"finding":"RBP4 directly stimulates basal lipolysis in human adipocytes in vitro. Additionally, conditioned media from RBP4-activated macrophages markedly increases basal lipolysis and impairs insulin-mediated lipolysis suppression; RBP4 treatment of macrophages increases TNFα production, indicating a paracrine mechanism linking RBP4-driven macrophage activation to adipocyte insulin resistance via pro-inflammatory cytokines.","method":"Direct RBP4 treatment of human adipocytes (in vitro lipolysis assay); conditioned media experiments from RBP4-activated macrophages applied to adipocytes; TNFα ELISA from macrophages","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct cell treatment and conditioned media experiments in human primary cells; multiple readouts; single lab","pmids":["32167208"],"is_preprint":false},{"year":2016,"finding":"Rbp4-deficient mice (C57BL/6 background) accumulate retinol in the liver but have undetectable serum retinol, demonstrating that RBP4 is critical for mobilization of retinol from hepatic storage pools into circulation. Loss of RBP4 causes severe retinal structural abnormalities (loss of peripheral choroid, photoreceptor layer degeneration, reduced ganglion cells) and ocular developmental defects (retinal depigmentation, optic disc abnormality, persistent hyaloid artery).","method":"Rbp4 knockout mice (C57BL/6 background); electroretinography; retinal histology; retinol measurement in serum and liver","journal":"Laboratory investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic knockout with quantitative retinoid and structural/functional retinal phenotyping; clear mechanistic interpretation of hepatic retinol mobilization","pmids":["26974396"],"is_preprint":false},{"year":2013,"finding":"A1120, a nonretinoid RBP4 antagonist, inhibits the RBP4–transthyretin (TTR) interaction in vitro with superior potency compared to fenretinide, does not inhibit RPE65-mediated isomerohydrolase activity, and reduces serum RBP4 by 75% in mice; this reduction correlates with decreased visual cycle retinoids and reduced ocular lipofuscin bisretinoid accumulation in Abca4−/− mice, confirming that RBP4–TTR interaction maintains circulating RBP4 levels required for retinal retinoid delivery.","method":"In vitro RBP4 binding assay; RBP4-TTR interaction assay; RPE microsome isomerohydrolase assay; in vivo mouse dosing with A1120; biochemical and electrophysiological measurement of retinoids and lipofuscin","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro mechanistic assays combined with in vivo pharmacological validation; multiple orthogonal readouts","pmids":["23211825"],"is_preprint":false},{"year":2013,"finding":"IL-1β downregulates RBP4 mRNA expression and secretion in human adipocytes in a time- and dose-dependent manner. This inhibitory effect is mediated via the IL-1 receptor and NF-κB, as blockade of IL-1 receptor or NF-κB inhibitors reverse the effect. TNF-α and LPS also inhibit RBP4 expression in macrophages, while IL-6 has no effect.","method":"IL-1β, TNF-α, LPS, IL-6 treatment of human SGBS and primary adipocytes; IL-1 receptor blocking antibody; NF-κB inhibitors (CAPE, SC-514); qPCR and ELISA for RBP4","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection (receptor blockade, NF-κB inhibition) in human primary cells with mRNA and protein readouts; single lab","pmids":["23460908"],"is_preprint":false},{"year":2009,"finding":"The minor allele (-803A) of the RBP4 promoter SNP increases RBP4 promoter activity 2–3 fold in 3T3-L1 adipocytes (shown by promoter-reporter assay), and this activity is further enhanced by 9-cis-retinoic acid and 8-Br-cAMP. EMSA showed that the -803G>A SNP modulates affinity for an unidentified DNA-binding suppressive factor, indicating that the minor allele relieves transcriptional repression to increase RBP4 adipocyte expression.","method":"Luciferase promoter activity assay in 3T3-L1 adipocytes; electrophoretic mobility shift assay (EMSA); allele-specific relative quantification of RBP4 transcripts in heterozygotes","journal":"Obesity (Silver Spring, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter assay and EMSA with allele-specific transcript quantification; single lab","pmids":["19851303"],"is_preprint":false},{"year":2022,"finding":"Exosomal RBP4 (derived primarily from hepatocytes) promotes M1-like polarization of Kupffer cells via NOX2/ROS/NF-κB pathway activation, leading to TNFα overproduction. TNFα in turn activates JAK2/STAT3 in hepatocytes to increase RBP4 transcription, creating a positive feedback loop that promotes hepatic lipid accumulation and NAFLD progression. Intravenous RBP4 injection in high-fat diet mice recapitulates hepatic lipid accumulation and M1 Kupffer cell polarization.","method":"Exosome isolation and characterization; in vitro co-culture of RBP4-treated Kupffer cells with hepatocytes; NOX2/NF-κB inhibition; Western blotting for JAK2/STAT3; intravenous RBP4 injection in HFD mice; lipogenesis gene expression analysis","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vitro mechanistic pathway dissection with pharmacological inhibitors and in vivo validation; single lab","pmids":["36572267"],"is_preprint":false},{"year":2024,"finding":"RBP4 promotes denervation-induced skeletal muscle fat infiltration and atrophy through a STRA6/JAK2/STAT3-dependent pathway. Holo-RBP4 increases STRA6 expression (>3-fold), promotes JAK2/STAT3 phosphorylation, increases atrophy markers Atrogin-1 and MuRF1, and decreases myogenesis regulators MyoD and MyoG in C2C12 myotubes. RBP4 knockout mice are protected from denervation-induced muscle atrophy. Inhibition of STRA6/JAK2/STAT3 by siRNA or pharmacological inhibitors, or by the RBP4 antagonist A1120, reduces atrophy markers and protects against muscle atrophy in vivo.","method":"RBP4 knockout mice; intramuscular injection of apo- or holo-RBP4; siRNA targeting STRA6/JAK2/STAT3; pharmacological inhibitors; A1120 treatment; C2C12 myotube experiments; immunofluorescence; Western blotting","journal":"Journal of cachexia, sarcopenia and muscle","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (KO), gain-of-function (injection), and pharmacological (A1120, siRNA, inhibitors) approaches with consistent mechanistic findings across in vitro and in vivo models","pmids":["39031684"],"is_preprint":false},{"year":2023,"finding":"Succinate triggers M2 polarization of macrophages via SUCNR1, and this polarization stimulates RBP4 secretion from macrophages. Secreted RBP4 then promotes endothelial tip cell formation and pathological angiogenesis via VEGFR2 signaling, linking macrophage metabolic state to vascular sprouting in ocular neovascularization.","method":"In vitro endothelial migration, invasion, and tubulation assays with macrophage-conditioned medium ± RBP4; SUCNR1 inhibition; choroidal neovascularization and oxygen-induced retinopathy mouse models; VEGFR2 pathway analysis","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vitro functional assays plus in vivo neovascularization models with defined receptor (VEGFR2) mechanism; single lab","pmids":["38129891"],"is_preprint":false},{"year":2018,"finding":"RBP4 overexpression in canine hepatocytes is impaired by an amino acid deletion (K12del) near the RBP4 N-terminus that disrupts protein folding in vivo, reducing secretion from hepatocytes into serum. The maternal penetrance effect in congenital eye disease arises from impaired sequential retinol transfer across the placenta, dependent on RBP4 encoded by both maternal and fetal genomes.","method":"Genetic analysis of canine pedigree (homozygous K12del); in vivo hepatocyte secretion assay; serum RBP4 measurement; NMR/structural analysis of mutant protein folding (referenced in abstract)","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model with biochemical measurement of secretion defect and in vivo placental transfer analysis; single study extending human findings","pmids":["29847795"],"is_preprint":false},{"year":2007,"finding":"In zebrafish, rbp4 is expressed in the yolk syncytial layer (YSL) during early embryogenesis and is required for yolk extension and liver bud formation. Knockdown of Rbp4 in the YSL results in shortened yolk extension and formation of two liver buds, attributed to impaired liver progenitor cell migration. rbp4 expression in the YSL is negatively regulated by Nodal and Hedgehog signaling and positively by retinoic acid; rbp4 regulates extracellular matrix protein Fibronectin1 specifically in ventrolateral yolk.","method":"Morpholino-mediated knockdown of rbp4 in zebrafish YSL; in situ hybridization; pathway inhibition (Nodal, Hedgehog, retinoic acid); Fibronectin1 expression analysis","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — zebrafish loss-of-function with specific developmental phenotype and pathway analysis; ortholog study in model organism consistent with mammalian RBP4 function","pmids":["17945029"],"is_preprint":false},{"year":2022,"finding":"RBP4 promotes proliferation and migration of vascular smooth muscle cells (VSMCs) via the JAK2/STAT3 signaling pathway. RBP4 overexpression in VSMCs increases JAK2, STAT3, cyclinD1, and Bcl-2 levels and enhances VSMC proliferation and migration. Vitamin D supplementation reduces these RBP4-induced changes and inhibits abnormal VSMC proliferation.","method":"RBP4 overexpression plasmid transfection in VSMCs; vitamin D treatment; Western blotting for JAK2/STAT3/cyclinD1/Bcl-2; proliferation and migration assays; in vivo rat diabetic atherosclerosis model","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — overexpression in cell culture with pathway readouts and in vivo correlation; single lab","pmids":["35082965"],"is_preprint":false},{"year":2014,"finding":"RBP4 enhances insulin-induced proliferation of vascular smooth muscle cells (RASMCs) and increases phosphorylation of ERK1/2 and JAK2. Blockade of ERK1/2 signaling with PD98059 inhibits RBP4-induced RASMC proliferation, whereas JAK2 inhibition with AG490 does not, identifying MAPK/ERK as the operative pathway for RBP4-induced VSMC proliferation in the context of hyperinsulinemia.","method":"RBP4 treatment of cultured rat aortic smooth muscle cells (RASMCs) ± insulin; ERK1/2 inhibitor (PD98059); JAK2 inhibitor (AG490); proliferation assay; Western blotting for p-ERK1/2 and p-JAK2","journal":"Endocrine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological pathway dissection in cell culture with specific inhibitors and proliferation readout; single lab","pmids":["24888764"],"is_preprint":false},{"year":2009,"finding":"RBP4 is expressed in macrophages (but not undifferentiated monocytes) and expression increases during monocyte-to-macrophage differentiation. RBP4 expression in macrophages is strongly inhibited by TNF-α and LPS but not by IL-6, demonstrating that macrophages are novel sites of RBP4 expression regulated by inflammatory stimuli.","method":"Monocyte-to-macrophage differentiation assay; treatment with TNF-α, IL-6, LPS; qPCR for RBP4 expression","journal":"Physiological research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, qPCR-based expression study during differentiation with pharmacological stimuli; no functional mechanistic follow-up","pmids":["19537932"],"is_preprint":false},{"year":2018,"finding":"RBP4 overexpression in ovarian cancer cells promotes migration and proliferation, inducing MMP2 and MMP9 expression via the RhoA/Rock1 and ERK pathways. RBP4 knockdown reduces cancer cell migration, proliferation, and oncogenic factor expression. The pro-migratory effect depends on retinol/retinoic acid associated with RBP4.","method":"RBP4 overexpression and siRNA knockdown in ovarian cancer cells; Transwell migration assay; MMP2/MMP9 expression; RhoA/Rock1 inhibition; CyclinD1 Western blotting","journal":"Journal of ovarian research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression/knockdown in cancer cell lines with pathway inhibition but no in vivo validation or mechanistic reconstitution","pmids":["29642915"],"is_preprint":false}],"current_model":"RBP4 is the principal hepatocyte-derived circulating retinol transporter that binds retinol in a hydrophobic pocket (also capable of binding fatty acids), associates with transthyretin (TTR) in plasma to prevent renal clearance, and delivers retinol to peripheral tissues via two receptors — STRA6 (high-affinity, bidirectional retinol channel in extrahepatic tissues) and RBPR2 (liver/intestine retinol transporter); at elevated concentrations RBP4 acts as a pro-inflammatory adipokine/hepatokine that activates adipose tissue macrophage antigen presentation via MyD88/JNK/NF-κB, drives CD4 T-cell Th1 polarization and adipose inflammation leading to insulin resistance, stimulates lipolysis and vascular smooth muscle cell proliferation via MAPK/ERK and JAK2/STAT3 pathways, and — through its receptor STRA6 — transduces a JAK2-STAT3 signaling cascade that promotes cancer stem cell maintenance and, in apo-RBP4 form, activates STAT5/SOCS3 to impair insulin signaling; hepatic RBP4 oscillates under circadian BMAL1→DBP transcriptional control, and its expression is suppressed by IL-1β via IL-1R/NF-κB in adipocytes and by retinol/retinoic acid in the liver."},"narrative":{"mechanistic_narrative":"RBP4 is the principal hepatocyte-derived circulating retinol carrier, mobilizing vitamin A from hepatic storage pools into the bloodstream for delivery to peripheral tissues; loss of RBP4 traps retinol in the liver, abolishes serum retinol, and causes severe retinal degeneration and ocular developmental defects [PMID:26974396, PMID:27797907]. Circulating RBP4 levels are sustained by its association with transthyretin (TTR), and disrupting this interaction — pharmacologically with the nonretinoid antagonist A1120 or by antisense knockdown of TTR — sharply lowers plasma RBP4 [PMID:23211825, PMID:25524914]. Beyond retinol, the hydrophobic ligand pocket of RBP4 also accommodates fatty acids such as palmitate and laurate [PMID:29414511]. Retinol delivery to cells is executed by two receptors: STRA6, a bidirectional retinol channel in extrahepatic tissues whose transfer activity is coupled to LRAT-driven retinyl ester formation, and RBPR2, a high-affinity hepatic/intestinal retinol transporter [PMID:18316031, PMID:23105095]. Dominant-negative RBP4 mutations that lose retinol binding yet bind STRA6 more avidly block productive vitamin A delivery and cause human ocular birth defects, with maternal transmission acting through impaired placental retinol transfer [PMID:25910211, PMID:29847795]. At elevated concentrations RBP4 functions as a pro-inflammatory adipokine/hepatokine: it activates adipose antigen-presenting cells through MyD88-dependent MAPK (JNK/ERK/p38) and NF-κB signaling, drives CD4 Th1 polarization and adipose inflammation sufficient to induce insulin resistance, and stimulates lipolysis via a TNFα-mediated paracrine loop [PMID:24606904, PMID:26936962, PMID:32167208]. Through STRA6, RBP4 transduces JAK2/STAT3 signaling that promotes colon cancer stem cell maintenance and denervation-induced skeletal muscle atrophy, while apo-RBP4 prolongs the RBP4–STRA6 interaction to activate STAT5/SOCS3 and impair insulin signaling [PMID:28689994, PMID:39031684, PMID:28528355]. Hepatic RBP4 expression oscillates under circadian BMAL1→DBP control to gate insulin sensitivity by time of day, and is regulated by HMGA1/cAMP and suppressed by IL-1β via IL-1R/NF-κB in adipocytes [PMID:26564180, PMID:19460132, PMID:23460908]. Notably, modestly elevated liver-secreted RBP4 alone does not impair glucose homeostasis, indicating that its metabolic pathogenicity depends on context such as adipose inflammation [PMID:30126844].","teleology":[{"year":2007,"claim":"Established an early developmental role for Rbp4 beyond adult retinol transport, showing it is required in the zebrafish yolk syncytial layer for yolk extension and proper liver bud formation.","evidence":"Morpholino knockdown in zebrafish YSL with in situ hybridization and pathway inhibition (Nodal, Hedgehog, retinoic acid)","pmids":["17945029"],"confidence":"Medium","gaps":["Mechanism linking Rbp4 to Fibronectin1 regulation not resolved","Relevance to mammalian liver/embryo development not established"]},{"year":2008,"claim":"Resolved how cells acquire retinol from circulating RBP4 by identifying STRA6 as a bidirectional retinol channel coupled to intracellular LRAT esterification.","evidence":"Cell-based retinol transfer assay in STRA6-expressing fibroblasts ± LRAT; zebrafish stra6/rbp4 loss-of-function with rescue","pmids":["18316031"],"confidence":"High","gaps":["Structural basis of bidirectional transport not defined","Tissue-specific contributions of STRA6 vs other routes unquantified"]},{"year":2009,"claim":"Defined transcriptional control of RBP4 by cAMP-HMGA1 signaling and by an adipocyte promoter SNP, linking RBP4 expression levels to glucose homeostasis.","evidence":"Hmga1 knockout mice with glucagon/cAMP stimulation; luciferase promoter-reporter and EMSA in 3T3-L1 adipocytes","pmids":["19460132","19851303"],"confidence":"Medium","gaps":["DNA-binding suppressive factor at the -803 SNP unidentified","Direct vs indirect HMGA1 action on the RBP4 promoter not distinguished"]},{"year":2012,"claim":"Identified a second RBP4 receptor, RBPR2, expanding retinol uptake beyond STRA6 to a high-affinity hepatic/intestinal route inversely tied to retinol stores.","evidence":"Heterologous expression with binding/transport assays, siRNA knockdown, and in vivo correlation with hepatic retinol","pmids":["23105095"],"confidence":"High","gaps":["Whether RBPR2 channels retinol bidirectionally like STRA6 unknown","In vivo physiological requirement via genetic knockout not shown"]},{"year":2013,"claim":"Established that the RBP4-TTR interaction maintains circulating RBP4 and is druggable, and that inflammatory cytokines suppress RBP4 expression.","evidence":"A1120 antagonist in vitro binding and in vivo dosing in Abca4-/- mice; IL-1β/TNF-α/LPS treatment with IL-1R blockade and NF-κB inhibitors in human adipocytes","pmids":["23211825","23460908"],"confidence":"High","gaps":["Physiological trigger normally regulating TTR-RBP4 complex dynamics unclear","Net consequence of cytokine-driven RBP4 suppression in vivo not established"]},{"year":2014,"claim":"Demonstrated that RBP4 acts as an immune signal sufficient to cause insulin resistance, activating adipose antigen-presenting cells via JNK to drive Th1 polarization, and identified MAPK/ERK as the route for VSMC proliferation.","evidence":"RBP4-overexpressing mice with adoptive transfer of activated APCs and JNK inhibition; RBP4 treatment of rat aortic SMCs with ERK (PD98059) and JAK2 (AG490) inhibitors","pmids":["24606904","24888764"],"confidence":"High","gaps":["Cell-surface receptor mediating APC activation not identified","Antigen specificity of induced T-cell response not defined"]},{"year":2015,"claim":"Resolved the upstream signaling for RBP4-induced inflammation and placed RBP4 downstream of the circadian clock as a hepatokine gating insulin sensitivity by time of day.","evidence":"MyD88-/- macrophages and pharmacological MAPK/NF-κB inhibition; CTLA4-Ig and RBP4-/- mice on high-fat diet; liver-specific Bmal1 KO with Dbp/Rbp4 knockdown and overexpression; human family genetics with mutant RBP4-STRA6 affinity measurements","pmids":["26936962","26564180","25910211"],"confidence":"High","gaps":["How MyD88 is engaged by RBP4 (receptor/ligand) remains undefined","Mechanism by which dominant-negative mutants sequester STRA6 not structurally resolved"]},{"year":2016,"claim":"Established hepatocytes as the dominant source of circulating RBP4 and confirmed RBP4's essential role in hepatic retinol mobilization and retinal integrity.","evidence":"Hepatocyte-specific RBP4 knockout (LRKO) and global Rbp4 knockout mice with serum/liver retinol measurement and retinal histology/ERG","pmids":["27797907","26974396"],"confidence":"High","gaps":["Contribution of intestinal/macrophage RBP4 to local signaling pools not quantified","Retinal phenotype mechanism downstream of retinol deficiency vs RBP4 signaling not separated"]},{"year":2017,"claim":"Showed that the retinol-loading state of RBP4 dictates STRA6 signaling output, with apo-RBP4 driving STAT5/SOCS3 insulin resistance and STRA6/JAK2/STAT3 promoting cancer stem cell maintenance.","evidence":"Co-IP distinguishing apo- vs holo-RBP4 binding to STRA6 in adipocytes with signaling readouts and in vivo rat injection; STRA6/RBP4 knockdown in colon cancer with sphere/tumor initiation and xenograft assays","pmids":["28528355","28689994"],"confidence":"Medium","gaps":["Apo- vs holo-RBP4 signaling distinction rests on a single lab's Co-IP","Structural basis for differential STRA6 engagement by ligand state unresolved"]},{"year":2018,"claim":"Refined the metabolic model by showing modest liver RBP4 elevation alone is insufficient for glucose dysregulation, and revealed fatty acids as a second physiological ligand.","evidence":"AAV liver-specific RBP4 overexpression with clamp/GTT on high-fat diet; high-resolution crystal structures of RBP4 from plasma/urine/amniotic fluid with mass spectrometry; canine K12del pedigree secretion analysis","pmids":["30126844","29414511","29847795"],"confidence":"High","gaps":["Functional consequence of fatty acid binding by RBP4 unknown","Context that converts elevated RBP4 into a pathogenic signal not pinpointed"]},{"year":2022,"claim":"Extended RBP4 pathology to NAFLD via an exosomal hepatocyte-Kupffer cell feedback loop and to vascular disease via JAK2/STAT3-driven VSMC proliferation.","evidence":"Exosome isolation with Kupffer cell co-culture, NOX2/NF-κB inhibition and in vivo RBP4 injection; RBP4 overexpression in VSMCs with vitamin D treatment and diabetic atherosclerosis rat model","pmids":["36572267","35082965"],"confidence":"Medium","gaps":["Receptor mediating exosomal RBP4 uptake by Kupffer cells unidentified","Both rest on single-lab cell-culture-driven mechanisms"]},{"year":2024,"claim":"Demonstrated a STRA6/JAK2/STAT3-dependent role for holo-RBP4 in denervation-induced muscle atrophy, with genetic and pharmacological (A1120) protection.","evidence":"RBP4 knockout mice, holo/apo-RBP4 intramuscular injection, STRA6/JAK2/STAT3 siRNA and inhibitors, A1120, and C2C12 myotube assays","pmids":["39031684"],"confidence":"High","gaps":["Source of RBP4 acting on denervated muscle (systemic vs local) not defined","Relationship between holo-RBP4 atrophy signaling and apo-RBP4 insulin resistance signaling unclear"]},{"year":null,"claim":"The molecular receptor and binding interface by which RBP4 activates immune cells (MyD88-dependent APC/macrophage responses) independent of STRA6 remain unidentified.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No receptor linking RBP4 to MyD88 engagement defined","Functional role of fatty-acid-bound RBP4 not established","Determinants converting elevated RBP4 into a pathogenic versus neutral signal unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[14,5,0,1]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[10]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,3,12,19]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[5,9,10]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[14,5,0]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,19,11,23]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,3,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,21]}],"complexes":["RBP4-transthyretin (TTR) complex"],"partners":["TTR","STRA6","RBPR2","LRAT"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P02753","full_name":"Retinol-binding protein 4","aliases":["Plasma retinol-binding protein","PRBP","RBP"],"length_aa":201,"mass_kda":23.0,"function":"Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P02753/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RBP4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RBP4","total_profiled":1310},"omim":[{"mim_id":"616428","title":"MICROPHTHALMIA/COLOBOMA 10; MCOPCB10","url":"https://www.omim.org/entry/616428"},{"mim_id":"615147","title":"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS","url":"https://www.omim.org/entry/615147"},{"mim_id":"610745","title":"STIMULATED BY RETINOIC ACID 6; STRA6","url":"https://www.omim.org/entry/610745"},{"mim_id":"600281","title":"HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A","url":"https://www.omim.org/entry/600281"},{"mim_id":"600165","title":"NANOPHTHALMOS 1; NNO1","url":"https://www.omim.org/entry/600165"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":11054.0}],"url":"https://www.proteinatlas.org/search/RBP4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P02753","domains":[{"cath_id":"2.40.128.20","chopping":"21-186","consensus_level":"medium","plddt":96.1744,"start":21,"end":186}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02753","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02753-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02753-F1-predicted_aligned_error_v6.png","plddt_mean":90.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RBP4","jax_strain_url":"https://www.jax.org/strain/search?query=RBP4"},"sequence":{"accession":"P02753","fasta_url":"https://rest.uniprot.org/uniprotkb/P02753.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02753/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02753"}},"corpus_meta":[{"pmid":"24606904","id":"PMC_24606904","title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24606904","citation_count":237,"is_preprint":false},{"pmid":"21835764","id":"PMC_21835764","title":"RBP4: a controversial adipokine.","date":"2011","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21835764","citation_count":181,"is_preprint":false},{"pmid":"17294166","id":"PMC_17294166","title":"Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.","date":"2007","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17294166","citation_count":158,"is_preprint":false},{"pmid":"18316031","id":"PMC_18316031","title":"RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18316031","citation_count":155,"is_preprint":false},{"pmid":"33790810","id":"PMC_33790810","title":"Biological Functions of RBP4 and Its Relevance for Human Diseases.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33790810","citation_count":152,"is_preprint":false},{"pmid":"23105095","id":"PMC_23105095","title":"Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23105095","citation_count":115,"is_preprint":false},{"pmid":"23584360","id":"PMC_23584360","title":"Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study.","date":"2013","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/23584360","citation_count":106,"is_preprint":false},{"pmid":"28689994","id":"PMC_28689994","title":"RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28689994","citation_count":90,"is_preprint":false},{"pmid":"17728376","id":"PMC_17728376","title":"Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17728376","citation_count":81,"is_preprint":false},{"pmid":"23211825","id":"PMC_23211825","title":"A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23211825","citation_count":78,"is_preprint":false},{"pmid":"27797907","id":"PMC_27797907","title":"Hepatocytes Are the Principal Source of Circulating RBP4 in Mice.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27797907","citation_count":73,"is_preprint":false},{"pmid":"21538175","id":"PMC_21538175","title":"Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein.","date":"2011","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/21538175","citation_count":71,"is_preprint":false},{"pmid":"18710473","id":"PMC_18710473","title":"Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18710473","citation_count":68,"is_preprint":false},{"pmid":"18752671","id":"PMC_18752671","title":"Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver.","date":"2008","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/18752671","citation_count":65,"is_preprint":false},{"pmid":"18496666","id":"PMC_18496666","title":"An RBP4 promoter polymorphism increases risk of type 2 diabetes.","date":"2008","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/18496666","citation_count":64,"is_preprint":false},{"pmid":"26936962","id":"PMC_26936962","title":"Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26936962","citation_count":59,"is_preprint":false},{"pmid":"25910211","id":"PMC_25910211","title":"Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910211","citation_count":58,"is_preprint":false},{"pmid":"23189188","id":"PMC_23189188","title":"Exome analysis identified a novel mutation in the RBP4 gene in a consanguineous pedigree with retinal dystrophy and developmental abnormalities.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23189188","citation_count":56,"is_preprint":false},{"pmid":"29642915","id":"PMC_29642915","title":"Adipokine RBP4 drives ovarian cancer cell migration.","date":"2018","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/29642915","citation_count":53,"is_preprint":false},{"pmid":"24956535","id":"PMC_24956535","title":"The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability.","date":"2014","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/24956535","citation_count":52,"is_preprint":false},{"pmid":"32167208","id":"PMC_32167208","title":"RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32167208","citation_count":51,"is_preprint":false},{"pmid":"17526940","id":"PMC_17526940","title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.","date":"2006","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/17526940","citation_count":50,"is_preprint":false},{"pmid":"19851303","id":"PMC_19851303","title":"Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI.","date":"2009","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19851303","citation_count":49,"is_preprint":false},{"pmid":"19288010","id":"PMC_19288010","title":"Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.","date":"2009","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19288010","citation_count":49,"is_preprint":false},{"pmid":"21645024","id":"PMC_21645024","title":"Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.","date":"2012","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21645024","citation_count":49,"is_preprint":false},{"pmid":"26917947","id":"PMC_26917947","title":"Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.","date":"2016","source":"Biomarker insights","url":"https://pubmed.ncbi.nlm.nih.gov/26917947","citation_count":48,"is_preprint":false},{"pmid":"20950077","id":"PMC_20950077","title":"Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.","date":"2010","source":"International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/20950077","citation_count":48,"is_preprint":false},{"pmid":"19537932","id":"PMC_19537932","title":"Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4).","date":"2009","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/19537932","citation_count":47,"is_preprint":false},{"pmid":"36572267","id":"PMC_36572267","title":"Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36572267","citation_count":47,"is_preprint":false},{"pmid":"29759068","id":"PMC_29759068","title":"Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study.","date":"2018","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/29759068","citation_count":47,"is_preprint":false},{"pmid":"29414511","id":"PMC_29414511","title":"Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/29414511","citation_count":46,"is_preprint":false},{"pmid":"19460132","id":"PMC_19460132","title":"The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.","date":"2009","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/19460132","citation_count":46,"is_preprint":false},{"pmid":"30126844","id":"PMC_30126844","title":"Liver-secreted RBP4 does not impair glucose homeostasis in mice.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30126844","citation_count":45,"is_preprint":false},{"pmid":"25524914","id":"PMC_25524914","title":"Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25524914","citation_count":45,"is_preprint":false},{"pmid":"26564180","id":"PMC_26564180","title":"RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice.","date":"2015","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/26564180","citation_count":45,"is_preprint":false},{"pmid":"26286643","id":"PMC_26286643","title":"Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26286643","citation_count":38,"is_preprint":false},{"pmid":"32095874","id":"PMC_32095874","title":"Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients.","date":"2020","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/32095874","citation_count":37,"is_preprint":false},{"pmid":"20544399","id":"PMC_20544399","title":"Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women.","date":"2010","source":"Obesity surgery","url":"https://pubmed.ncbi.nlm.nih.gov/20544399","citation_count":37,"is_preprint":false},{"pmid":"23129325","id":"PMC_23129325","title":"Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.","date":"2012","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/23129325","citation_count":34,"is_preprint":false},{"pmid":"34177800","id":"PMC_34177800","title":"RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia.","date":"2021","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34177800","citation_count":30,"is_preprint":false},{"pmid":"22397743","id":"PMC_22397743","title":"Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?","date":"2012","source":"European journal of obstetrics, gynecology, and reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/22397743","citation_count":30,"is_preprint":false},{"pmid":"18199128","id":"PMC_18199128","title":"Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population.","date":"2008","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/18199128","citation_count":29,"is_preprint":false},{"pmid":"26974396","id":"PMC_26974396","title":"Severe ocular phenotypes in Rbp4-deficient mice in the C57BL/6 genetic background.","date":"2016","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26974396","citation_count":29,"is_preprint":false},{"pmid":"17945029","id":"PMC_17945029","title":"Localized rbp4 expression in the yolk syncytial layer plays a role in yolk cell extension and early liver development.","date":"2007","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17945029","citation_count":28,"is_preprint":false},{"pmid":"26611784","id":"PMC_26611784","title":"Association of RBP4 genetic variants with childhood obesity and cardiovascular risk factors.","date":"2015","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26611784","citation_count":28,"is_preprint":false},{"pmid":"22253430","id":"PMC_22253430","title":"Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22253430","citation_count":28,"is_preprint":false},{"pmid":"21324757","id":"PMC_21324757","title":"High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis.","date":"2011","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/21324757","citation_count":28,"is_preprint":false},{"pmid":"18466349","id":"PMC_18466349","title":"Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18466349","citation_count":28,"is_preprint":false},{"pmid":"19857477","id":"PMC_19857477","title":"Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes.","date":"2009","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19857477","citation_count":28,"is_preprint":false},{"pmid":"28026829","id":"PMC_28026829","title":"Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance.","date":"2016","source":"Postepy higieny i medycyny doswiadczalnej (Online)","url":"https://pubmed.ncbi.nlm.nih.gov/28026829","citation_count":27,"is_preprint":false},{"pmid":"21039728","id":"PMC_21039728","title":"Human RBP4 adipose tissue expression is gender specific and influenced by leptin.","date":"2011","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21039728","citation_count":27,"is_preprint":false},{"pmid":"27511589","id":"PMC_27511589","title":"An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach.","date":"2016","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27511589","citation_count":27,"is_preprint":false},{"pmid":"24994759","id":"PMC_24994759","title":"Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria.","date":"2014","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24994759","citation_count":26,"is_preprint":false},{"pmid":"24011638","id":"PMC_24011638","title":"Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity.","date":"2013","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/24011638","citation_count":25,"is_preprint":false},{"pmid":"20798476","id":"PMC_20798476","title":"Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese--the Tanno and Sobetsu study.","date":"2010","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/20798476","citation_count":25,"is_preprint":false},{"pmid":"30015949","id":"PMC_30015949","title":"RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30015949","citation_count":24,"is_preprint":false},{"pmid":"24695672","id":"PMC_24695672","title":"Proteomic Analysis of RBP4/Vitamin A in Children with Cleft Lip and/or Palate.","date":"2014","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/24695672","citation_count":24,"is_preprint":false},{"pmid":"29524177","id":"PMC_29524177","title":"Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older.","date":"2018","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29524177","citation_count":24,"is_preprint":false},{"pmid":"22670657","id":"PMC_22670657","title":"Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.","date":"2012","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22670657","citation_count":24,"is_preprint":false},{"pmid":"28528355","id":"PMC_28528355","title":"Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.","date":"2017","source":"Archives of gynecology and obstetrics","url":"https://pubmed.ncbi.nlm.nih.gov/28528355","citation_count":23,"is_preprint":false},{"pmid":"34786060","id":"PMC_34786060","title":"LncRNA PTGS2 regulates islet β-cell function through the miR-146a-5p/RBP4 axis and its diagnostic value in type 2 diabetes mellitus.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34786060","citation_count":23,"is_preprint":false},{"pmid":"35629362","id":"PMC_35629362","title":"Green Coffee Bean Extract Normalize Obesity-Induced Alterations of Metabolic Parameters in Rats by Upregulating Adiponectin and GLUT4 Levels and Reducing RBP-4 and HOMA-IR.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35629362","citation_count":22,"is_preprint":false},{"pmid":"38129891","id":"PMC_38129891","title":"Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization.","date":"2023","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38129891","citation_count":21,"is_preprint":false},{"pmid":"19893506","id":"PMC_19893506","title":"Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population.","date":"2009","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19893506","citation_count":21,"is_preprint":false},{"pmid":"29122953","id":"PMC_29122953","title":"Dietary weight loss-induced changes in RBP4, FFA, and ACE predict weight regain in people with overweight and obesity.","date":"2017","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/29122953","citation_count":21,"is_preprint":false},{"pmid":"39031684","id":"PMC_39031684","title":"RBP4 promotes denervation-induced muscle atrophy through STRA6-dependent pathway.","date":"2024","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/39031684","citation_count":20,"is_preprint":false},{"pmid":"33376518","id":"PMC_33376518","title":"Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33376518","citation_count":20,"is_preprint":false},{"pmid":"30135138","id":"PMC_30135138","title":"Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes.","date":"2018","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/30135138","citation_count":20,"is_preprint":false},{"pmid":"33082885","id":"PMC_33082885","title":"The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis.","date":"2020","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/33082885","citation_count":20,"is_preprint":false},{"pmid":"20576168","id":"PMC_20576168","title":"Non-additive effects of RBP4, ESR1 and IGF2 polymorphisms on litter size at different parities in a Chinese-European porcine line.","date":"2010","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/20576168","citation_count":20,"is_preprint":false},{"pmid":"30805369","id":"PMC_30805369","title":"Relationships of SLC2A4, RBP4, PCK1, and PI3K Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/30805369","citation_count":19,"is_preprint":false},{"pmid":"37312059","id":"PMC_37312059","title":"Shift work is associated with an increased risk of type 2 diabetes and elevated RBP4 level: cross sectional analysis from the OHSPIW cohort study.","date":"2023","source":"BMC public health","url":"https://pubmed.ncbi.nlm.nih.gov/37312059","citation_count":18,"is_preprint":false},{"pmid":"23028466","id":"PMC_23028466","title":"Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis--a kinetic analysis on retinol/retinoic acid homeostatic system.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23028466","citation_count":18,"is_preprint":false},{"pmid":"35082965","id":"PMC_35082965","title":"The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35082965","citation_count":17,"is_preprint":false},{"pmid":"35631143","id":"PMC_35631143","title":"Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35631143","citation_count":17,"is_preprint":false},{"pmid":"31956331","id":"PMC_31956331","title":"Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model.","date":"2020","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31956331","citation_count":17,"is_preprint":false},{"pmid":"24888764","id":"PMC_24888764","title":"Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/24888764","citation_count":17,"is_preprint":false},{"pmid":"23460908","id":"PMC_23460908","title":"Interleukin-1β downregulates RBP4 secretion in human adipocytes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23460908","citation_count":17,"is_preprint":false},{"pmid":"24739026","id":"PMC_24739026","title":"Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.","date":"2014","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24739026","citation_count":17,"is_preprint":false},{"pmid":"23408763","id":"PMC_23408763","title":"Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men.","date":"2013","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23408763","citation_count":17,"is_preprint":false},{"pmid":"21521262","id":"PMC_21521262","title":"High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease.","date":"2011","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21521262","citation_count":16,"is_preprint":false},{"pmid":"18324929","id":"PMC_18324929","title":"High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.","date":"2008","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18324929","citation_count":16,"is_preprint":false},{"pmid":"29786448","id":"PMC_29786448","title":"Serum RBP4 positively correlates with triglyceride level but not with BMI, fat mass and insulin resistance in healthy obese and non-obese individuals.","date":"2018","source":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/29786448","citation_count":16,"is_preprint":false},{"pmid":"25479076","id":"PMC_25479076","title":"A genetic polymorphism in RBP4 is associated with coronary artery disease.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25479076","citation_count":16,"is_preprint":false},{"pmid":"24665145","id":"PMC_24665145","title":"RBP4 gene variants are associated with insulin resistance in women with previous gestational diabetes.","date":"2014","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/24665145","citation_count":16,"is_preprint":false},{"pmid":"34041677","id":"PMC_34041677","title":"Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/34041677","citation_count":15,"is_preprint":false},{"pmid":"25633269","id":"PMC_25633269","title":"First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.","date":"2014","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/25633269","citation_count":15,"is_preprint":false},{"pmid":"33484131","id":"PMC_33484131","title":"Systematic Quantification of Neurotrophic Adipokines RBP4, PEDF, and Clusterin in Human Cerebrospinal Fluid and Serum.","date":"2021","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33484131","citation_count":14,"is_preprint":false},{"pmid":"33198782","id":"PMC_33198782","title":"Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a cross-sectional study.","date":"2020","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/33198782","citation_count":14,"is_preprint":false},{"pmid":"30186876","id":"PMC_30186876","title":"Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention.","date":"2018","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/30186876","citation_count":14,"is_preprint":false},{"pmid":"34856473","id":"PMC_34856473","title":"A novel regulatory mechanism of geniposide for improving glucose homeostasis mediated by circulating RBP4.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34856473","citation_count":14,"is_preprint":false},{"pmid":"21406189","id":"PMC_21406189","title":"Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA).","date":"2011","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21406189","citation_count":14,"is_preprint":false},{"pmid":"28813718","id":"PMC_28813718","title":"Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/28813718","citation_count":13,"is_preprint":false},{"pmid":"29428584","id":"PMC_29428584","title":"The preliminary association study of ADIPOQ, RBP4, and BCMO1 variants with polycystic ovary syndrome and with biochemical characteristics in a cohort of Polish women.","date":"2018","source":"Advances in medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29428584","citation_count":13,"is_preprint":false},{"pmid":"29847795","id":"PMC_29847795","title":"Maternal Inheritance of a Recessive RBP4 Defect in Canine Congenital Eye Disease.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29847795","citation_count":13,"is_preprint":false},{"pmid":"31659433","id":"PMC_31659433","title":"Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31659433","citation_count":13,"is_preprint":false},{"pmid":"38532976","id":"PMC_38532976","title":"Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis.","date":"2024","source":"Frontiers in public health","url":"https://pubmed.ncbi.nlm.nih.gov/38532976","citation_count":12,"is_preprint":false},{"pmid":"26885398","id":"PMC_26885398","title":"Association of RBP4 Genotype with Phenotypic Reproductive Traits of Sows.","date":"2016","source":"Genetics research international","url":"https://pubmed.ncbi.nlm.nih.gov/26885398","citation_count":12,"is_preprint":false},{"pmid":"35883591","id":"PMC_35883591","title":"Effect of Upregulation of Transcription Factor TFDP1 Binding Promoter Activity Due to RBP4 g.36491960G>C Mutation on the Proliferation of Goat Granulosa Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35883591","citation_count":12,"is_preprint":false},{"pmid":"23979787","id":"PMC_23979787","title":"The effects of weight loss on FABP4 and RBP4 in obese women with metabolic syndrome.","date":"2013","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/23979787","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":59306,"output_tokens":8119,"usd":0.149851,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17814,"output_tokens":4911,"usd":0.105923,"stage2_stop_reason":"end_turn"},"total_usd":0.255774,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"STRA6 mediates bidirectional retinol transfer between RBP4 and cells; this transfer is enhanced by lecithin:retinol acyltransferase (LRAT) and is bidirectional, indicating STRA6 functions as a retinol channel/transporter. In zebrafish lacking Stra6, holo-Rbp4 causes nonspecific vitamin A excess in embryonic tissues, impairing retinoic acid receptor signaling; reducing Rbp4 levels alleviates these defects.\",\n      \"method\": \"Cell-based retinol transfer assay (NIH 3T3 fibroblasts expressing STRA6 ± LRAT); zebrafish loss-of-function (morpholino knockdown of stra6 and rbp4); pharmacological treatment\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstituted retinol transport in cultured cells with mechanistic follow-up, bidirectionality established, orthogonal in vivo zebrafish model with rescue experiment\",\n      \"pmids\": [\"18316031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RBPR2 (RBP4 receptor-2) is a novel retinol transporter expressed primarily in liver and intestine that confers high-affinity RBP4 binding and retinol transport when expressed in cultured cells; RBPR2 knockdown reduces RBP4 binding and retinol transport. RBPR2 expression is suppressed by retinol and retinoic acid and correlates inversely with liver retinol stores in vivo, identifying it as a hepatic receptor for circulating RBP4.\",\n      \"method\": \"Heterologous expression in cultured cells (binding and transport assays); siRNA knockdown; in vivo correlation of RBPR2 expression with retinol stores\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional expression with binding/transport assay, knockdown confirmation, in vivo correlation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"23105095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RBP4 directly activates adipose tissue antigen-presenting cells (APCs) through a JNK-dependent pathway, leading to CD4 T cell Th1 polarization and adipose tissue inflammation. Transfer of RBP4-activated APCs into normal mice is sufficient to induce adipose tissue inflammation, insulin resistance, and glucose intolerance.\",\n      \"method\": \"RBP4-overexpressing mouse model (RBP4-Ox); adoptive transfer of RBP4-activated APCs into normal mice; JNK pathway inhibition\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — adoptive transfer experiment establishes sufficiency, genetic model establishes necessity, pathway inhibition identifies JNK as mediator; replicated in follow-up study (PMID 26936962)\",\n      \"pmids\": [\"24606904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RBP4-induced macrophage antigen presentation and T-cell activation requires MyD88 signaling and downstream MAPK (JNK, ERK, p38) and NF-κB pathways. In macrophages from MyD88−/− mice, RBP4 fails to stimulate TNF, IL-12, and IL-6 secretion or CD4 T-cell activation. In vivo blockade of antigen presentation with CTLA4-Ig reduces adipose tissue inflammation and improves insulin resistance in RBP4-Ox mice. RBP4−/− mice on high-fat diet show reduced adipose tissue inflammation and improved insulin sensitivity.\",\n      \"method\": \"MyD88−/− macrophages; pharmacological inhibition of JNK/ERK/p38/NF-κB; CTLA4-Ig treatment in vivo; RBP4−/− knockout mice on high-fat diet\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (MyD88 KO, RBP4 KO) and pharmacological loss-of-function, multiple orthogonal approaches, replication of mechanism from PMID 24606904\",\n      \"pmids\": [\"26936962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dominant-negative missense mutations in RBP4 greatly reduce retinol binding yet paradoxically increase RBP4 affinity for its cell-surface receptor STRA6. By occupying STRA6 nonproductively, these mutant proteins disrupt vitamin A delivery by wild-type RBP4 both within the fetus and, for maternally transmitted alleles, at the placenta, establishing a dominant-negative mechanism for ocular birth defects.\",\n      \"method\": \"Structural/biochemical analysis of mutant RBP4 retinol-binding and STRA6-binding affinities; genetic analysis of three human families with eye malformations; maternal transmission studies\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biochemical characterization of mutant protein–receptor interaction combined with human genetic analysis demonstrating dominant-negative mechanism; multiple orthogonal approaches in single rigorous study\",\n      \"pmids\": [\"25910211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hepatocytes are the principal source of circulating RBP4. Liver-specific RBP4 knockout mice have undetectable circulating RBP4 despite intact and inducible adipose tissue RBP4 expression and secretion, demonstrating that adipocyte-derived RBP4 does not significantly contribute to circulating levels even in diet-induced insulin resistance.\",\n      \"method\": \"Hepatocyte-specific Cre-mediated RBP4 deletion (LRKO mice); measurement of serum RBP4 and adipose RBP4 expression/secretion in lean and obese states\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific genetic knockout with quantitative assessment of circulating and tissue RBP4; clear epistatic result\",\n      \"pmids\": [\"27797907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Liver-specific overexpression of RBP4 via AAV to levels comparable to obesity-associated elevation does not impair glucose homeostasis in mice, even under high-fat diet challenge, indicating that modestly elevated liver-secreted circulating RBP4 is not itself causative for impaired glucose metabolism.\",\n      \"method\": \"Adeno-associated virus (AAV)-mediated liver-specific RBP4 overexpression; glucose tolerance tests; insulin clamp; high-fat diet challenge\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic gain-of-function model with multiple metabolic readouts; negative finding robustly established with rigorous controls\",\n      \"pmids\": [\"30126844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGA1 transcription factor is required for basal and cAMP-induced RBP4 gene and protein expression. In Hmga1-knockout mice, basal and glucagon-induced RBP4 expression is severely attenuated. This identifies a cAMP–HMGA1–RBP4 pathway regulating glucose homeostasis, where RBP4 reduction correlates inversely with increased GLUT4 and activated Akt in skeletal muscle and fat.\",\n      \"method\": \"Hmga1 knockout mouse model; glucagon administration; cAMP treatment of cells; mRNA and protein quantification of RBP4 and GLUT4/Akt\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout and pharmacological stimulation, multiple readouts; single lab\",\n      \"pmids\": [\"19460132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hepatic RBP4 expression oscillates diurnally under circadian control. BMAL1 regulates hepatic RBP4 via its direct target DBP. Hepatic knockdown of RBP4 or DBP improves whole-body insulin sensitivity in a time-of-day-dependent manner; hepatic overexpression of RBP4 reverses insulin-sensitizing effects of liver-specific BMAL1 depletion, placing RBP4 as a hepatokine downstream of the circadian clock regulating glucose metabolism.\",\n      \"method\": \"Liver-specific Bmal1 knockout mice; recombinant adenovirus-mediated shRNA knockdown of Dbp or Rbp4 in liver; hepatic RBP4 overexpression; insulin sensitivity tests at different times of day\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic models (KO, KD, OE) with functional glucose metabolism readouts; single lab\",\n      \"pmids\": [\"26564180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Circulating transthyretin (TTR) is a critical determinant of plasma RBP4 levels. Antisense oligonucleotide-mediated knockdown of TTR decreases circulating TTR and RBP4 by 80–95%, improving insulin sensitivity in obese mice (increased glucose infusion rate, greater suppression of hepatic glucose production, increased muscle glucose uptake), demonstrating that TTR-RBP4 complex formation is required for maintaining elevated circulating RBP4.\",\n      \"method\": \"TTR antisense oligonucleotide (ASO) treatment in ob/ob and high-fat diet mice; hyperinsulinemic-euglycemic clamp; hepatic glucose production measurement; insulin signaling in muscle\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological targeting of TTR-RBP4 interaction with quantitative metabolic phenotyping; multiple models and orthogonal readouts\",\n      \"pmids\": [\"25524914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human plasma RBP4, in addition to retinol, binds fatty acids (including palmitic and lauric acid) in its hydrophobic ligand-binding site. High-resolution crystal structures of human RBP4 from plasma, urine, and amniotic fluid all showed a fatty acid molecule bound in the retinol-binding pocket, confirmed by mass spectrometry.\",\n      \"method\": \"X-ray crystallography (high-resolution 3D structures of apo- and holo-RBP4 from plasma, urine, amniotic fluid); mass spectrometry confirmation of fatty acid binding\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures at high resolution with mass spectrometry confirmation; single lab but Tier 1 method\",\n      \"pmids\": [\"29414511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"STRA6, activated by RBP4, transduces a JAK2-STAT3 signaling cascade that promotes cancer stem cell maintenance in colon cancer. Downregulation of STRA6 or RBP4 decreases cancer stem cell fraction and sphere/tumor initiation frequency. High-fat diet increases STRA6 levels and promotes tumor growth in a xenograft model; STRA6 downregulation delays tumor initiation and impairs stemness marker expression.\",\n      \"method\": \"STRA6/RBP4 siRNA knockdown in colon cancer cells; sphere formation and tumor initiation assays; xenograft mouse model; high-fat diet mouse model\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in vitro and in vivo with defined stem cell phenotype; single lab, multiple approaches\",\n      \"pmids\": [\"28689994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Retinol-free RBP4 (apo-RBP4), but not retinol-bound RBP4 (holo-RBP4), activates STRA6 signaling and induces insulin resistance. In vitro, apo-RBP4 prolongs RBP4–STRA6 interaction (shown by co-immunoprecipitation) and elevates JAK2/STAT5 cascade activation and SOCS3 expression, while decreasing IR/IRS1 phosphorylation and GLUT4 translocation. Exogenous apo-RBP4 injection into pregnant rats attenuates insulin sensitivity.\",\n      \"method\": \"Co-immunoprecipitation of RBP4 with STRA6 in human adipocytes treated with apo- vs. holo-RBP4; Western blotting of JAK2/STAT5/SOCS3/IR/IRS1; GLUT4 translocation by immunofluorescence; in vivo apo-RBP4 injection in pregnant rats\",\n      \"journal\": \"Archives of gynecology and obstetrics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP distinguishing apo vs. holo forms, multiple signaling readouts, in vivo validation; single lab\",\n      \"pmids\": [\"28528355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RBP4 directly stimulates basal lipolysis in human adipocytes in vitro. Additionally, conditioned media from RBP4-activated macrophages markedly increases basal lipolysis and impairs insulin-mediated lipolysis suppression; RBP4 treatment of macrophages increases TNFα production, indicating a paracrine mechanism linking RBP4-driven macrophage activation to adipocyte insulin resistance via pro-inflammatory cytokines.\",\n      \"method\": \"Direct RBP4 treatment of human adipocytes (in vitro lipolysis assay); conditioned media experiments from RBP4-activated macrophages applied to adipocytes; TNFα ELISA from macrophages\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct cell treatment and conditioned media experiments in human primary cells; multiple readouts; single lab\",\n      \"pmids\": [\"32167208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Rbp4-deficient mice (C57BL/6 background) accumulate retinol in the liver but have undetectable serum retinol, demonstrating that RBP4 is critical for mobilization of retinol from hepatic storage pools into circulation. Loss of RBP4 causes severe retinal structural abnormalities (loss of peripheral choroid, photoreceptor layer degeneration, reduced ganglion cells) and ocular developmental defects (retinal depigmentation, optic disc abnormality, persistent hyaloid artery).\",\n      \"method\": \"Rbp4 knockout mice (C57BL/6 background); electroretinography; retinal histology; retinol measurement in serum and liver\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic knockout with quantitative retinoid and structural/functional retinal phenotyping; clear mechanistic interpretation of hepatic retinol mobilization\",\n      \"pmids\": [\"26974396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A1120, a nonretinoid RBP4 antagonist, inhibits the RBP4–transthyretin (TTR) interaction in vitro with superior potency compared to fenretinide, does not inhibit RPE65-mediated isomerohydrolase activity, and reduces serum RBP4 by 75% in mice; this reduction correlates with decreased visual cycle retinoids and reduced ocular lipofuscin bisretinoid accumulation in Abca4−/− mice, confirming that RBP4–TTR interaction maintains circulating RBP4 levels required for retinal retinoid delivery.\",\n      \"method\": \"In vitro RBP4 binding assay; RBP4-TTR interaction assay; RPE microsome isomerohydrolase assay; in vivo mouse dosing with A1120; biochemical and electrophysiological measurement of retinoids and lipofuscin\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro mechanistic assays combined with in vivo pharmacological validation; multiple orthogonal readouts\",\n      \"pmids\": [\"23211825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IL-1β downregulates RBP4 mRNA expression and secretion in human adipocytes in a time- and dose-dependent manner. This inhibitory effect is mediated via the IL-1 receptor and NF-κB, as blockade of IL-1 receptor or NF-κB inhibitors reverse the effect. TNF-α and LPS also inhibit RBP4 expression in macrophages, while IL-6 has no effect.\",\n      \"method\": \"IL-1β, TNF-α, LPS, IL-6 treatment of human SGBS and primary adipocytes; IL-1 receptor blocking antibody; NF-κB inhibitors (CAPE, SC-514); qPCR and ELISA for RBP4\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection (receptor blockade, NF-κB inhibition) in human primary cells with mRNA and protein readouts; single lab\",\n      \"pmids\": [\"23460908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The minor allele (-803A) of the RBP4 promoter SNP increases RBP4 promoter activity 2–3 fold in 3T3-L1 adipocytes (shown by promoter-reporter assay), and this activity is further enhanced by 9-cis-retinoic acid and 8-Br-cAMP. EMSA showed that the -803G>A SNP modulates affinity for an unidentified DNA-binding suppressive factor, indicating that the minor allele relieves transcriptional repression to increase RBP4 adipocyte expression.\",\n      \"method\": \"Luciferase promoter activity assay in 3T3-L1 adipocytes; electrophoretic mobility shift assay (EMSA); allele-specific relative quantification of RBP4 transcripts in heterozygotes\",\n      \"journal\": \"Obesity (Silver Spring, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter assay and EMSA with allele-specific transcript quantification; single lab\",\n      \"pmids\": [\"19851303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Exosomal RBP4 (derived primarily from hepatocytes) promotes M1-like polarization of Kupffer cells via NOX2/ROS/NF-κB pathway activation, leading to TNFα overproduction. TNFα in turn activates JAK2/STAT3 in hepatocytes to increase RBP4 transcription, creating a positive feedback loop that promotes hepatic lipid accumulation and NAFLD progression. Intravenous RBP4 injection in high-fat diet mice recapitulates hepatic lipid accumulation and M1 Kupffer cell polarization.\",\n      \"method\": \"Exosome isolation and characterization; in vitro co-culture of RBP4-treated Kupffer cells with hepatocytes; NOX2/NF-κB inhibition; Western blotting for JAK2/STAT3; intravenous RBP4 injection in HFD mice; lipogenesis gene expression analysis\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vitro mechanistic pathway dissection with pharmacological inhibitors and in vivo validation; single lab\",\n      \"pmids\": [\"36572267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RBP4 promotes denervation-induced skeletal muscle fat infiltration and atrophy through a STRA6/JAK2/STAT3-dependent pathway. Holo-RBP4 increases STRA6 expression (>3-fold), promotes JAK2/STAT3 phosphorylation, increases atrophy markers Atrogin-1 and MuRF1, and decreases myogenesis regulators MyoD and MyoG in C2C12 myotubes. RBP4 knockout mice are protected from denervation-induced muscle atrophy. Inhibition of STRA6/JAK2/STAT3 by siRNA or pharmacological inhibitors, or by the RBP4 antagonist A1120, reduces atrophy markers and protects against muscle atrophy in vivo.\",\n      \"method\": \"RBP4 knockout mice; intramuscular injection of apo- or holo-RBP4; siRNA targeting STRA6/JAK2/STAT3; pharmacological inhibitors; A1120 treatment; C2C12 myotube experiments; immunofluorescence; Western blotting\",\n      \"journal\": \"Journal of cachexia, sarcopenia and muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (KO), gain-of-function (injection), and pharmacological (A1120, siRNA, inhibitors) approaches with consistent mechanistic findings across in vitro and in vivo models\",\n      \"pmids\": [\"39031684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Succinate triggers M2 polarization of macrophages via SUCNR1, and this polarization stimulates RBP4 secretion from macrophages. Secreted RBP4 then promotes endothelial tip cell formation and pathological angiogenesis via VEGFR2 signaling, linking macrophage metabolic state to vascular sprouting in ocular neovascularization.\",\n      \"method\": \"In vitro endothelial migration, invasion, and tubulation assays with macrophage-conditioned medium ± RBP4; SUCNR1 inhibition; choroidal neovascularization and oxygen-induced retinopathy mouse models; VEGFR2 pathway analysis\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vitro functional assays plus in vivo neovascularization models with defined receptor (VEGFR2) mechanism; single lab\",\n      \"pmids\": [\"38129891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RBP4 overexpression in canine hepatocytes is impaired by an amino acid deletion (K12del) near the RBP4 N-terminus that disrupts protein folding in vivo, reducing secretion from hepatocytes into serum. The maternal penetrance effect in congenital eye disease arises from impaired sequential retinol transfer across the placenta, dependent on RBP4 encoded by both maternal and fetal genomes.\",\n      \"method\": \"Genetic analysis of canine pedigree (homozygous K12del); in vivo hepatocyte secretion assay; serum RBP4 measurement; NMR/structural analysis of mutant protein folding (referenced in abstract)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model with biochemical measurement of secretion defect and in vivo placental transfer analysis; single study extending human findings\",\n      \"pmids\": [\"29847795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In zebrafish, rbp4 is expressed in the yolk syncytial layer (YSL) during early embryogenesis and is required for yolk extension and liver bud formation. Knockdown of Rbp4 in the YSL results in shortened yolk extension and formation of two liver buds, attributed to impaired liver progenitor cell migration. rbp4 expression in the YSL is negatively regulated by Nodal and Hedgehog signaling and positively by retinoic acid; rbp4 regulates extracellular matrix protein Fibronectin1 specifically in ventrolateral yolk.\",\n      \"method\": \"Morpholino-mediated knockdown of rbp4 in zebrafish YSL; in situ hybridization; pathway inhibition (Nodal, Hedgehog, retinoic acid); Fibronectin1 expression analysis\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — zebrafish loss-of-function with specific developmental phenotype and pathway analysis; ortholog study in model organism consistent with mammalian RBP4 function\",\n      \"pmids\": [\"17945029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RBP4 promotes proliferation and migration of vascular smooth muscle cells (VSMCs) via the JAK2/STAT3 signaling pathway. RBP4 overexpression in VSMCs increases JAK2, STAT3, cyclinD1, and Bcl-2 levels and enhances VSMC proliferation and migration. Vitamin D supplementation reduces these RBP4-induced changes and inhibits abnormal VSMC proliferation.\",\n      \"method\": \"RBP4 overexpression plasmid transfection in VSMCs; vitamin D treatment; Western blotting for JAK2/STAT3/cyclinD1/Bcl-2; proliferation and migration assays; in vivo rat diabetic atherosclerosis model\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — overexpression in cell culture with pathway readouts and in vivo correlation; single lab\",\n      \"pmids\": [\"35082965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RBP4 enhances insulin-induced proliferation of vascular smooth muscle cells (RASMCs) and increases phosphorylation of ERK1/2 and JAK2. Blockade of ERK1/2 signaling with PD98059 inhibits RBP4-induced RASMC proliferation, whereas JAK2 inhibition with AG490 does not, identifying MAPK/ERK as the operative pathway for RBP4-induced VSMC proliferation in the context of hyperinsulinemia.\",\n      \"method\": \"RBP4 treatment of cultured rat aortic smooth muscle cells (RASMCs) ± insulin; ERK1/2 inhibitor (PD98059); JAK2 inhibitor (AG490); proliferation assay; Western blotting for p-ERK1/2 and p-JAK2\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological pathway dissection in cell culture with specific inhibitors and proliferation readout; single lab\",\n      \"pmids\": [\"24888764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RBP4 is expressed in macrophages (but not undifferentiated monocytes) and expression increases during monocyte-to-macrophage differentiation. RBP4 expression in macrophages is strongly inhibited by TNF-α and LPS but not by IL-6, demonstrating that macrophages are novel sites of RBP4 expression regulated by inflammatory stimuli.\",\n      \"method\": \"Monocyte-to-macrophage differentiation assay; treatment with TNF-α, IL-6, LPS; qPCR for RBP4 expression\",\n      \"journal\": \"Physiological research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, qPCR-based expression study during differentiation with pharmacological stimuli; no functional mechanistic follow-up\",\n      \"pmids\": [\"19537932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RBP4 overexpression in ovarian cancer cells promotes migration and proliferation, inducing MMP2 and MMP9 expression via the RhoA/Rock1 and ERK pathways. RBP4 knockdown reduces cancer cell migration, proliferation, and oncogenic factor expression. The pro-migratory effect depends on retinol/retinoic acid associated with RBP4.\",\n      \"method\": \"RBP4 overexpression and siRNA knockdown in ovarian cancer cells; Transwell migration assay; MMP2/MMP9 expression; RhoA/Rock1 inhibition; CyclinD1 Western blotting\",\n      \"journal\": \"Journal of ovarian research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression/knockdown in cancer cell lines with pathway inhibition but no in vivo validation or mechanistic reconstitution\",\n      \"pmids\": [\"29642915\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RBP4 is the principal hepatocyte-derived circulating retinol transporter that binds retinol in a hydrophobic pocket (also capable of binding fatty acids), associates with transthyretin (TTR) in plasma to prevent renal clearance, and delivers retinol to peripheral tissues via two receptors — STRA6 (high-affinity, bidirectional retinol channel in extrahepatic tissues) and RBPR2 (liver/intestine retinol transporter); at elevated concentrations RBP4 acts as a pro-inflammatory adipokine/hepatokine that activates adipose tissue macrophage antigen presentation via MyD88/JNK/NF-κB, drives CD4 T-cell Th1 polarization and adipose inflammation leading to insulin resistance, stimulates lipolysis and vascular smooth muscle cell proliferation via MAPK/ERK and JAK2/STAT3 pathways, and — through its receptor STRA6 — transduces a JAK2-STAT3 signaling cascade that promotes cancer stem cell maintenance and, in apo-RBP4 form, activates STAT5/SOCS3 to impair insulin signaling; hepatic RBP4 oscillates under circadian BMAL1→DBP transcriptional control, and its expression is suppressed by IL-1β via IL-1R/NF-κB in adipocytes and by retinol/retinoic acid in the liver.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RBP4 is the principal hepatocyte-derived circulating retinol carrier, mobilizing vitamin A from hepatic storage pools into the bloodstream for delivery to peripheral tissues; loss of RBP4 traps retinol in the liver, abolishes serum retinol, and causes severe retinal degeneration and ocular developmental defects [#14, #5]. Circulating RBP4 levels are sustained by its association with transthyretin (TTR), and disrupting this interaction — pharmacologically with the nonretinoid antagonist A1120 or by antisense knockdown of TTR — sharply lowers plasma RBP4 [#15, #9]. Beyond retinol, the hydrophobic ligand pocket of RBP4 also accommodates fatty acids such as palmitate and laurate [#10]. Retinol delivery to cells is executed by two receptors: STRA6, a bidirectional retinol channel in extrahepatic tissues whose transfer activity is coupled to LRAT-driven retinyl ester formation, and RBPR2, a high-affinity hepatic/intestinal retinol transporter [#0, #1]. Dominant-negative RBP4 mutations that lose retinol binding yet bind STRA6 more avidly block productive vitamin A delivery and cause human ocular birth defects, with maternal transmission acting through impaired placental retinol transfer [#4, #21]. At elevated concentrations RBP4 functions as a pro-inflammatory adipokine/hepatokine: it activates adipose antigen-presenting cells through MyD88-dependent MAPK (JNK/ERK/p38) and NF-\\u03baB signaling, drives CD4 Th1 polarization and adipose inflammation sufficient to induce insulin resistance, and stimulates lipolysis via a TNF\\u03b1-mediated paracrine loop [#2, #3, #13]. Through STRA6, RBP4 transduces JAK2/STAT3 signaling that promotes colon cancer stem cell maintenance and denervation-induced skeletal muscle atrophy, while apo-RBP4 prolongs the RBP4\\u2013STRA6 interaction to activate STAT5/SOCS3 and impair insulin signaling [#11, #19, #12]. Hepatic RBP4 expression oscillates under circadian BMAL1\\u2192DBP control to gate insulin sensitivity by time of day, and is regulated by HMGA1/cAMP and suppressed by IL-1\\u03b2 via IL-1R/NF-\\u03baB in adipocytes [#8, #7, #16]. Notably, modestly elevated liver-secreted RBP4 alone does not impair glucose homeostasis, indicating that its metabolic pathogenicity depends on context such as adipose inflammation [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established an early developmental role for Rbp4 beyond adult retinol transport, showing it is required in the zebrafish yolk syncytial layer for yolk extension and proper liver bud formation.\",\n      \"evidence\": \"Morpholino knockdown in zebrafish YSL with in situ hybridization and pathway inhibition (Nodal, Hedgehog, retinoic acid)\",\n      \"pmids\": [\"17945029\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking Rbp4 to Fibronectin1 regulation not resolved\", \"Relevance to mammalian liver/embryo development not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved how cells acquire retinol from circulating RBP4 by identifying STRA6 as a bidirectional retinol channel coupled to intracellular LRAT esterification.\",\n      \"evidence\": \"Cell-based retinol transfer assay in STRA6-expressing fibroblasts ± LRAT; zebrafish stra6/rbp4 loss-of-function with rescue\",\n      \"pmids\": [\"18316031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of bidirectional transport not defined\", \"Tissue-specific contributions of STRA6 vs other routes unquantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined transcriptional control of RBP4 by cAMP-HMGA1 signaling and by an adipocyte promoter SNP, linking RBP4 expression levels to glucose homeostasis.\",\n      \"evidence\": \"Hmga1 knockout mice with glucagon/cAMP stimulation; luciferase promoter-reporter and EMSA in 3T3-L1 adipocytes\",\n      \"pmids\": [\"19460132\", \"19851303\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding suppressive factor at the -803 SNP unidentified\", \"Direct vs indirect HMGA1 action on the RBP4 promoter not distinguished\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified a second RBP4 receptor, RBPR2, expanding retinol uptake beyond STRA6 to a high-affinity hepatic/intestinal route inversely tied to retinol stores.\",\n      \"evidence\": \"Heterologous expression with binding/transport assays, siRNA knockdown, and in vivo correlation with hepatic retinol\",\n      \"pmids\": [\"23105095\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RBPR2 channels retinol bidirectionally like STRA6 unknown\", \"In vivo physiological requirement via genetic knockout not shown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that the RBP4-TTR interaction maintains circulating RBP4 and is druggable, and that inflammatory cytokines suppress RBP4 expression.\",\n      \"evidence\": \"A1120 antagonist in vitro binding and in vivo dosing in Abca4-/- mice; IL-1\\u03b2/TNF-\\u03b1/LPS treatment with IL-1R blockade and NF-\\u03baB inhibitors in human adipocytes\",\n      \"pmids\": [\"23211825\", \"23460908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger normally regulating TTR-RBP4 complex dynamics unclear\", \"Net consequence of cytokine-driven RBP4 suppression in vivo not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that RBP4 acts as an immune signal sufficient to cause insulin resistance, activating adipose antigen-presenting cells via JNK to drive Th1 polarization, and identified MAPK/ERK as the route for VSMC proliferation.\",\n      \"evidence\": \"RBP4-overexpressing mice with adoptive transfer of activated APCs and JNK inhibition; RBP4 treatment of rat aortic SMCs with ERK (PD98059) and JAK2 (AG490) inhibitors\",\n      \"pmids\": [\"24606904\", \"24888764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-surface receptor mediating APC activation not identified\", \"Antigen specificity of induced T-cell response not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved the upstream signaling for RBP4-induced inflammation and placed RBP4 downstream of the circadian clock as a hepatokine gating insulin sensitivity by time of day.\",\n      \"evidence\": \"MyD88-/- macrophages and pharmacological MAPK/NF-\\u03baB inhibition; CTLA4-Ig and RBP4-/- mice on high-fat diet; liver-specific Bmal1 KO with Dbp/Rbp4 knockdown and overexpression; human family genetics with mutant RBP4-STRA6 affinity measurements\",\n      \"pmids\": [\"26936962\", \"26564180\", \"25910211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MyD88 is engaged by RBP4 (receptor/ligand) remains undefined\", \"Mechanism by which dominant-negative mutants sequester STRA6 not structurally resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established hepatocytes as the dominant source of circulating RBP4 and confirmed RBP4's essential role in hepatic retinol mobilization and retinal integrity.\",\n      \"evidence\": \"Hepatocyte-specific RBP4 knockout (LRKO) and global Rbp4 knockout mice with serum/liver retinol measurement and retinal histology/ERG\",\n      \"pmids\": [\"27797907\", \"26974396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of intestinal/macrophage RBP4 to local signaling pools not quantified\", \"Retinal phenotype mechanism downstream of retinol deficiency vs RBP4 signaling not separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that the retinol-loading state of RBP4 dictates STRA6 signaling output, with apo-RBP4 driving STAT5/SOCS3 insulin resistance and STRA6/JAK2/STAT3 promoting cancer stem cell maintenance.\",\n      \"evidence\": \"Co-IP distinguishing apo- vs holo-RBP4 binding to STRA6 in adipocytes with signaling readouts and in vivo rat injection; STRA6/RBP4 knockdown in colon cancer with sphere/tumor initiation and xenograft assays\",\n      \"pmids\": [\"28528355\", \"28689994\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apo- vs holo-RBP4 signaling distinction rests on a single lab's Co-IP\", \"Structural basis for differential STRA6 engagement by ligand state unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refined the metabolic model by showing modest liver RBP4 elevation alone is insufficient for glucose dysregulation, and revealed fatty acids as a second physiological ligand.\",\n      \"evidence\": \"AAV liver-specific RBP4 overexpression with clamp/GTT on high-fat diet; high-resolution crystal structures of RBP4 from plasma/urine/amniotic fluid with mass spectrometry; canine K12del pedigree secretion analysis\",\n      \"pmids\": [\"30126844\", \"29414511\", \"29847795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of fatty acid binding by RBP4 unknown\", \"Context that converts elevated RBP4 into a pathogenic signal not pinpointed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended RBP4 pathology to NAFLD via an exosomal hepatocyte-Kupffer cell feedback loop and to vascular disease via JAK2/STAT3-driven VSMC proliferation.\",\n      \"evidence\": \"Exosome isolation with Kupffer cell co-culture, NOX2/NF-\\u03baB inhibition and in vivo RBP4 injection; RBP4 overexpression in VSMCs with vitamin D treatment and diabetic atherosclerosis rat model\",\n      \"pmids\": [\"36572267\", \"35082965\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating exosomal RBP4 uptake by Kupffer cells unidentified\", \"Both rest on single-lab cell-culture-driven mechanisms\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated a STRA6/JAK2/STAT3-dependent role for holo-RBP4 in denervation-induced muscle atrophy, with genetic and pharmacological (A1120) protection.\",\n      \"evidence\": \"RBP4 knockout mice, holo/apo-RBP4 intramuscular injection, STRA6/JAK2/STAT3 siRNA and inhibitors, A1120, and C2C12 myotube assays\",\n      \"pmids\": [\"39031684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of RBP4 acting on denervated muscle (systemic vs local) not defined\", \"Relationship between holo-RBP4 atrophy signaling and apo-RBP4 insulin resistance signaling unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular receptor and binding interface by which RBP4 activates immune cells (MyD88-dependent APC/macrophage responses) independent of STRA6 remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No receptor linking RBP4 to MyD88 engagement defined\", \"Functional role of fatty-acid-bound RBP4 not established\", \"Determinants converting elevated RBP4 into a pathogenic versus neutral signal unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [14, 5, 0, 1]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 3, 12, 19]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [5, 9, 10]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [14, 5, 0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 19, 11, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 3, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 21]}\n    ],\n    \"complexes\": [\"RBP4-transthyretin (TTR) complex\"],\n    \"partners\": [\"TTR\", \"STRA6\", \"RBPR2\", \"LRAT\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":9,"faith_total":9,"faith_pct":100.0}}